The latest research by Kincentric, a Spencer Stuart company focused on improving leadership impact by unlocking the power of people and teams, identifies a number of compelling business outcomes that can be achieved when organizations deliver a consistent and cohesive employee experience (EX) across the organization. The Global Employee Experience Trends 2023 Report reveals that employee engagement has plateaued over the last five years, and CEOs and CHROs must now shift their approach to EX if they want to accelerate business outcomes through their people.

The study, backed by extensive data from over nine million respondents across 2500 organizations, 162 countries and 62 industries, emphasizes the need for leaders to act on employee experience more holistically, with consistency of experience emerging as a key factor in driving business impact. In addition to consistency, which is achieved when multiple core experience elements create similar positive perceptions across employees, the report also outlines the importance of the alignment of EX to culture and business strategy, as well as endorsement by the C-suite. The data indicates that leading organizations are enjoying notable advantages in terms of employee engagement, retention, financial performance and customer satisfaction as a result of this groundbreaking new approach.

Key findings of the research include:

- Ratings of customer satisfaction and financial performance are over 2X higher when the work experience is consistent, yet almost one third (29%) of employees have a highly inconsistent experience, with significant negative impact on engagement and business outcomes.
- Employee engagement is 5.5X higher when EX is aligned to culture and strategy, yet only 36% of organizations have indicators that all three elements are truly aligned.
- Nearly half (49%) of employees feel their employers are failing to provide the employee experience they were promised.
- Senior leaders have 6X the impact on the consistency of EX compared to managers, demonstrating their critical role in bringing this to life.

In addition, Kincentric's 2023 report indicates employees have increased expectations regarding their day-to-day work experience, and while employees have expressed more positivity around things such as long-term career aspirations and virtual work arrangements, there has been a decline in measures around inspirational leadership, organizational values and support and connection.

According to Jeff Jolton, Managing Director of Research and Insights at Kincentric, leaders looking to drive exceptional business results should focus on the transformative power of a consistent and cohesive EX, instead of solely measuring employee engagement as an outcome. "Organizations must take a fresh, holistic and highly intentional approach to drive greater consistency in their EX - which is not about providing the same experience for everyone, but instead, striving to ensure employees have the same positive perception of the work experience." Jolton says. "The reality is that the majority of organizations globally are not providing the level of consistency required to translate EX into critical business outcomes and are missing a huge opportunity to unlock the full potential of their people and create competitive advantage."

Click HERE to learn more or to review the study highlights and full research report. https://www.kincentric.com/insights/global-employee-experience-trends-2023

About Kincentric

Kincentric, a Spencer Stuart company, helps organizations unlock the power of people and teams to ignite change and drive better business results. With decades of experience and specialist expertise in areas such as culture, employee engagement, leadership assessment and development, HR and talent advisory, and diversity, equity and inclusion, we use data-driven insights to architect solutions that add value, enhance agility and increase organizational effectiveness. For more information, visit kincentric.com.




Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest News

韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ

韓国・ソウル, Dec 13, 2025 - (JCN Newswire) - 韓国のブロックチェーンおよびデジタル経済分野で新たな動きが報じられている。政治、社会団体、メディア、国際交流など多分野で活動する金載德(Kim Jae-duk)氏が、ブロックチェーン連盟会長およびMOVA Chainエコシステム支援者として関与を開始し、MOVAプロジェクトが韓国で広く注目されている。

京東工業登陸港交所:業績與品牌雙賦能 長期成長潛力可期

香港, Dec 12, 2025 - (ACN Newswire) - 中國領先的工業供應鏈技術與服務提供商 - 京東工業(股份代號:7618.HK)正式登陸香港聯合交易所。

  
...

京东工业登陆港交所:业绩与品牌双赋能 长期成长潜力可期

香港, Dec 12, 2025 - (ACN Newswire) - 中国领先的工业供应链技术与服务提供商,京东工业(股份代号:7618.HK)正式登陆香港联合交易所。

  
...

京東工業配售結果出爐:MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值

香港, Dec 12, 2025 - (ACN Newswire) - 京东工业股份有限公司(「京東工業」或「公司」,股份代號:7618.HK)正式公佈全球發售配發結果。

  
...

京东工业配售结果出炉:MRO龙头实力领跑 全链条数智化解决方案释放长期价值

香港, Dec 12, 2025 - (ACN Newswire) - 京东工业股份有限公司(「京东工业」或「公司」,股份代号:7618.HK)正式公布全球发售配发结果。

  
...

全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值

香港, Dec 12, 2025 - (ACN Newswire) - 在產業升級、數智化轉型加速及政策支持等多重因素驅動下,工業供應鏈技術正迎來爆發式發展期。

  
...

全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值

香港, Dec 12, 2025 - (ACN Newswire) - 在产业升级、数智化转型加速及政策支持等多重因素驱动下,工业供应链技术正迎来爆发式发展期。

  
...

首隻山水實景表演概念股 印象大紅袍啟動香港公開募股

香港, Dec 12, 2025 - (ACN Newswire) - 中國領先的文旅服務企業 – 印象大紅袍股份有限公司 (新三板股票代碼:870608)(「公司」或「印象大紅袍」)今日宣佈啟動香港公開發售計劃(「香港公開發售」),計劃於香港聯合交易所有限公司(「香港聯交所」)主板上市(股份代號:2695)。

首只山水实景表演概念股 印象大红袍启动香港公开募股

香港, Dec 12, 2025 - (ACN Newswire) - 中国领先的文旅服务企业 – 印象大红袍股份有限公司 (新三板股票代码:870608)(「公司」或「印象大红袍」)今日宣布启动香港公开发售计划(「香港公开发售」),计划于香港联合交易所有限公司(「香港联交所」)主板上市(股份代号:2695)。

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten

HONG KONG, Dec 12, 2025 - (ACN Newswire) - Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd ('Everest Medicines China'), has entered into two strategic agreements with privately

雲頂新耀與海森生物簽署商業化服務協議及授權許可協議 推動商業化協同與多領域佈局

香港, Dec 12, 2025 - (ACN Newswire) - 雲頂新耀(Everest Medicines,HKEX 1952.HK)于2025年12月11日,宣佈其全資附屬公司雲頂新耀醫藥科技有限公司(以下簡稱:「雲頂新耀醫藥科技」)已與海森生物醫藥有限公司(以下簡稱:「海森生物」)簽署兩項戰略合作協議,包括商業化服務協議以及授權許可協議。

云顶新耀与海森生物签署商业化服务协议及授权许可协议 推动商业化协同与多领域布局

香港, Dec 12, 2025 - (ACN Newswire) - 云顶新耀(Everest Medicines,HKEX 1952.HK)于2025年12月11日宣布,其全资附属公司云顶新耀医药科技有限公司(以下简称:"云顶新耀医药科技")已与海森生物医药有限公司(以下简称:"海森生物")签署两项战略合作协议,包括商业化服务协议以及授权许可协议。

國泰海通成功發行非銀金融機構首單上海自貿離岸債

香港, Dec 12, 2025 - (ACN Newswire) - 12月11日,國泰海通集團下屬公司國泰君安國際控股有限公司(「國泰君安國際」或「公司」,股份代號:1788.HK)擔任配售代理牽頭行,協助國泰海通金融控股有限公司(以下簡稱「國泰海通金控」)成功發行非銀金融機構首單上海自貿離岸債,發行規模為5億元離岸人民幣,期限為364天,票面利率為1.8%,由上海清算所登記託管。

国泰海通成功发行非银金融机构首单上海自贸离岸债

香港, Dec 12, 2025 - (ACN Newswire) - 12月11日,国泰海通集团下属公司国泰君安国际控股有限公司("国泰君安国际"或"公司",股份代号:1788.HK)担任配售代理牵头行,协助国泰海通金融控股有限公司(以下简称"国泰海通金控")成功发行非银金融机构首单上海自贸离岸债,发行规模为5亿元离岸人民币,期限为364天,票面利率为1.8%,由上海清算所登记托管。

紮根西藏 本土化團隊協同鑄就「礦業堡壘」!智匯礦業IPO背後的本土化競爭力

香港, Dec 12, 2025 - (ACN Newswire) - 今年以來,港股市場新股活躍度明顯回暖,不少具有成長屬性與獨特賽道優勢的企業受到市場關注。從資源、科技到新能源賽道,具備稀缺性、週期穿越能力與強現金流特徵的企業,更成為資金追逐的焦點。

  
...

Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition

TOKYO, Dec 12, 2025 - (JCN Newswire) - We are pleased to announce that a variety of events will be held in conjunction with the ongoing "Digimon Adventure 02" & "Magical DoReMi #" ANIME 25TH ANNIVERSARY JOINT EXHIBITION.

萬億工業賽道迎來「智慧樞紐」:解碼京東工業的價值邏輯

香港, Dec 11, 2025 - (ACN Newswire) - 12 月 11 日,京東工業(07618.HK)正式登陸港交所,為京東生態資本市場佈局再添重要一子。

  
...

HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion

HONG KONG, Dec 11, 2025 - (JCN Newswire) - Hong Kong's exports are expected to grow by between 8% and 9% in 2026, according to figures releaased today by the Hong Kong Trade Development Council (HKTDC).

国泰君安国际荣登《商业周刊》彭博绿金2026值得关注榜 - 绿色金融机构榜单

香港, Dec 11, 2025 - (ACN Newswire) - 近日,《商业周刊》彭博绿金2026值得关注榜单在上海正式发布。国泰海通集团下属公司国泰君安国际控股有限公司("国泰君安国际"或"公司",股份代号:1788.HK)凭借在绿色金融领域的卓越表现与创新实践,成功入选"绿色金融机构榜单"。

國泰君安國際榮登《商業週刊》彭博綠金2026值得關注榜 - 綠色金融機構榜單

香港, Dec 11, 2025 - (ACN Newswire) - 近日,《商業週刊》彭博綠金2026值得關注榜單在上海正式發佈。

國泰君安國際蟬聯《信報財經新聞》上市公司卓越大獎

香港, Dec 11, 2025 - (ACN Newswire) - 由香港專業財經媒體《信報財經新聞》主辦的「上市公司卓越大獎2025」頒獎典禮在香港成功舉辦。

国泰君安国际蝉联《信报财经新闻》上市公司卓越大奖

香港, Dec 11, 2025 - (ACN Newswire) - 由香港专业财经媒体《信报财经新闻》主办的"上市公司卓越大奖2025"颁奖典礼在香港成功举办。

康哲藥業(0867)抗急性缺血性卒中創新藥注射用Y-3中國NDA獲受理

深圳, Dec 11, 2025 - (ACN Newswire) - 康哲藥業控股有限公司("康哲藥業")欣然宣佈,1類新藥注射用Y-3(擬定中文通用名:注射用洛貝米柳)("注射用Y-3"或"產品")新藥上市許可申請(NDA)已於2025年12月11日獲得中國國家藥品監督管理局(NMPA)受理。

More Press Releases >>